Prosecution Insights
Last updated: November 04, 2026

Alector LLC

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Alector LLC maintains a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The data shows 1 pending office action currently in progress. This action is being reviewed by 1 distinct examiner, indicating a focused prosecution phase.

The examination is taking place within 1 distinct art unit, which matches the 1 distinct examiner involved. CHANG YU WANG is the busiest examiner for this portfolio, holding 1 busiest examiner pending office action. Since the total pending office actions for the company is 1, this examiner is handling the entire active workload.

This concentration suggests that the company's current patenting efforts are specialized within a single technical domain. Practitioners will need to focus their efforts on the 1 distinct examiner, CHANG YU WANG, who is the sole official reviewing the pending matter. The 1 pending office action represents a streamlined administrative path within the Biotechnology & Pharmaceuticals sector, requiring a targeted response to the 1 distinct art unit involved.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
2
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
STOICA, ELLY GERALD 1 66.8% +22.6%
WANG, CHANG YU 1 33.3% +53.8%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17782127 METHODS OF USE OF ANTI-TREM2 ANTIBODIES WANG, CHANG YU 19d
18637627 SIGLEC-9 ECD Fusion Molecules and Methods of Use Thereof STOICA, ELLY GERALD —

Top Art Units

Art UnitApps
1647 1
1675 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18637627 SIGLEC-9 ECD Fusion Molecules and Methods of Use Thereof STOICA, ELLY GERALD 1647 §112 Non-Final OA — Pending Apr 17, 2024
17782127 METHODS OF USE OF ANTI-TREM2 ANTIBODIES WANG, CHANG YU 1675 §112 Final Rejection 19d Pending Jun 02, 2022

Managing Alector LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Alector LLC have?

Alector LLC has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Alector LLC applications?

Elly Gerald Stoica has the most, with 1 of Alector LLC's pending office actions.

What technology area are Alector LLC's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month